Change In Japan’s OTC Laws Bodes Changes In Buying Habits
This article was originally published in PharmAsia News
Executive Summary
A major change in Japan's laws governing the sale of over-the-counter drugs is expected to lead to a major change in consumer buying habits when it takes effect next April. As of that month, supermarkets and other large retailers are to be allowed to sell OTC drugs, currently confined to pharmacies. A price battle between the two groups is expected to result from relaxation of the pharmaceutical affairs law, placing pressure on drugstores that have seen rapid growth recently, but now face a need to change business models. The law change would remove the current requirement that limits OTC drug sales to pharmacists, allowing regular sales staff to sell the drugs after a year of drug-selling experience and a "registered drug seller" license. (Click here for more - a subscription may be required
You may also be interested in...
Japan’s OTC Market Rebounds On Brisk Lifestyle-Illness Drug Sales
TOKYO - While Japan's $70 billion pharmaceutical market is shrinking in value in line with the annual lowering of government health insurance drug prices, one sector is registering growth that industry officials describe as rather unexpected: the over-the-counter market for drugs that treat common colds to traditional Chinese medicines for metabolic syndrome
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.